Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 83

1.

Impact of Powdered Vancomycin on Preventing Surgical Site Infections in Neurosurgery: A Systematic Review and Meta-analysis.

Texakalidis P, Lu VM, Yolcu Y, Kerezoudis P, Alvi MA, Parney IF, Fogelson JL, Bydon M.

Neurosurgery. 2018 Jul 3. doi: 10.1093/neuros/nyy288. [Epub ahead of print]

PMID:
29982615
2.

Efficacy of the MDM2 inhibitor SAR405838 in glioblastoma is limited by poor distribution across the blood-brain barrier.

Kim M, Ma DJ, Calligaris D, Zhang S, Feathers RW, Vaubel RA, Meaux I, Mladek AC, Parrish KE, Jin F, Barriere C, Debussche L, Watters J, Tian S, Decker PA, Eckel-Passow JE, Kitange GJ, Johnson AJ, Parney IF, Anastasiadis PZ, Agar NYR, Elmquist WF, Sarkaria JN.

Mol Cancer Ther. 2018 Jul 3. pii: molcanther.0600.2017. doi: 10.1158/1535-7163.MCT-17-0600. [Epub ahead of print]

PMID:
29970480
3.

Insurance Correlates with Improved Access to Care and Outcome Among Glioblastoma Patients.

Brown DA, Himes BT, Kerezoudis P, Chilinda-Salter YM, Grewal SS, Spear JA, Bydon M, Burns TC, Parney IF.

Neuro Oncol. 2018 Jun 11. doi: 10.1093/neuonc/noy102. [Epub ahead of print]

PMID:
29893906
4.

Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy.

Kurokawa C, Iankov ID, Anderson SK, Aderca I, Leontovich AA, Maurer MJ, Oberg AL, Schroeder MA, Giannini C, Greiner SM, Becker MA, Thompson EA, Haluska P, Jentoft ME, Parney IF, Weroha SJ, Jen J, Sarkaria JN, Galanis E.

J Natl Cancer Inst. 2018 May 16. doi: 10.1093/jnci/djy033. [Epub ahead of print]

PMID:
29788332
5.

Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas.

Youland RS, Pafundi DH, Brinkmann DH, Lowe VJ, Morris JM, Kemp BJ, Hunt CH, Giannini C, Parney IF, Laack NN.

J Neurooncol. 2018 May;137(3):583-591. doi: 10.1007/s11060-018-2750-7. Epub 2018 Jan 13.

PMID:
29330751
6.

Cranial Tumor Surgical Outcomes at a High-Volume Academic Referral Center.

Brown DA, Himes BT, Major BT, Mundell BF, Kumar R, Kall B, Meyer FB, Link MJ, Pollock BE, Atkinson JD, Van Gompel JJ, Marsh WR, Lanzino G, Bydon M, Parney IF.

Mayo Clin Proc. 2018 Jan;93(1):16-24. doi: 10.1016/j.mayocp.2017.08.023.

PMID:
29304919
7.

Outcomes following cerebrospinal fluid shunting in high-grade glioma patients.

Rinaldo L, Brown D, Lanzino G, Parney IF.

J Neurosurg. 2017 Dec 22:1-13. doi: 10.3171/2017.6.JNS17859. [Epub ahead of print]

PMID:
29271709
8.

Adult Pilocytic Astrocytoma: An Institutional Series and Systematic Literature Review for Extent of Resection and Recurrence.

Bond KM, Hughes JD, Porter AL, Orina J, Fang S, Parney IF.

World Neurosurg. 2018 Feb;110:276-283. doi: 10.1016/j.wneu.2017.11.102. Epub 2017 Nov 24. Review.

PMID:
29180079
9.

Gamma Knife Stereotactic Radiosurgery for the Treatment of Primary and Metastatic Ocular Malignancies.

Arnett ALH, Reynolds MM, Pulido JS, Parney IF, Laack NN.

Stereotact Funct Neurosurg. 2017;95(6):363-368. doi: 10.1159/000478271. Epub 2017 Nov 4.

PMID:
29131131
10.

MR Elastography Analysis of Glioma Stiffness and IDH1-Mutation Status.

Pepin KM, McGee KP, Arani A, Lake DS, Glaser KJ, Manduca A, Parney IF, Ehman RL, Huston J 3rd.

AJNR Am J Neuroradiol. 2018 Jan;39(1):31-36. doi: 10.3174/ajnr.A5415. Epub 2017 Oct 26.

11.

Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data.

Sarkaria JN, Hu LS, Parney IF, Pafundi DH, Brinkmann DH, Laack NN, Giannini C, Burns TC, Kizilbash SH, Laramy JK, Swanson KR, Kaufmann TJ, Brown PD, Agar NYR, Galanis E, Buckner JC, Elmquist WF.

Neuro Oncol. 2018 Jan 22;20(2):184-191. doi: 10.1093/neuonc/nox175.

PMID:
29016900
12.

Residual Deep Convolutional Neural Network Predicts MGMT Methylation Status.

Korfiatis P, Kline TL, Lachance DH, Parney IF, Buckner JC, Erickson BJ.

J Digit Imaging. 2017 Oct;30(5):622-628. doi: 10.1007/s10278-017-0009-z.

PMID:
28785873
13.

Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.

Brown PD, Ballman KV, Cerhan JH, Anderson SK, Carrero XW, Whitton AC, Greenspoon J, Parney IF, Laack NNI, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG 2nd, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D.

Lancet Oncol. 2017 Aug;18(8):1049-1060. doi: 10.1016/S1470-2045(17)30441-2. Epub 2017 Jul 4.

PMID:
28687377
14.

Modulating glioma-mediated myeloid-derived suppressor cell development with sulforaphane.

Kumar R, de Mooij T, Peterson TE, Kaptzan T, Johnson AJ, Daniels DJ, Parney IF.

PLoS One. 2017 Jun 30;12(6):e0179012. doi: 10.1371/journal.pone.0179012. eCollection 2017.

15.

Predicting Deletion of Chromosomal Arms 1p/19q in Low-Grade Gliomas from MR Images Using Machine Intelligence.

Akkus Z, Ali I, Sedlář J, Agrawal JP, Parney IF, Giannini C, Erickson BJ.

J Digit Imaging. 2017 Aug;30(4):469-476. doi: 10.1007/s10278-017-9984-3.

16.

Gamma knife radiosurgery for the treatment of uveal melanoma and uveal metastases.

Reynolds MM, Arnett AL, Parney IF, Kumar R, Laack NN, Maloney PR, Kozelsky TF, Garces YI, Foote RL, Pulido JS.

Int J Retina Vitreous. 2017 May 29;3:17. doi: 10.1186/s40942-017-0070-2. eCollection 2017.

17.

Patterns of care and treatment outcomes in older adults with low grade glioma: a 50-year experience.

Youland RS, Schomas DA, Brown PD, Parney IF, Laack NNI.

J Neurooncol. 2017 Jun;133(2):339-346. doi: 10.1007/s11060-017-2439-3. Epub 2017 Apr 21.

PMID:
28432585
18.

The Risk of Radiation-Induced Tumors or Malignant Transformation After Single-Fraction Intracranial Radiosurgery: Results Based on a 25-Year Experience.

Pollock BE, Link MJ, Stafford SL, Parney IF, Garces YI, Foote RL.

Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):919-923. doi: 10.1016/j.ijrobp.2017.01.004. Epub 2017 Jan 9.

PMID:
28333013
19.

Genetically Defined Oligodendroglioma Is Characterized by Indistinct Tumor Borders at MRI.

Johnson DR, Diehn FE, Giannini C, Jenkins RB, Jenkins SM, Parney IF, Kaufmann TJ.

AJNR Am J Neuroradiol. 2017 Apr;38(4):678-684. doi: 10.3174/ajnr.A5070. Epub 2017 Jan 26.

20.

MRI texture features as biomarkers to predict MGMT methylation status in glioblastomas.

Korfiatis P, Kline TL, Coufalova L, Lachance DH, Parney IF, Carter RE, Buckner JC, Erickson BJ.

Med Phys. 2016 Jun;43(6):2835-2844. doi: 10.1118/1.4948668.

Supplemental Content

Loading ...
Support Center